EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $471,000 | -60.2% | 9,400 | -50.0% | 0.00% | -50.0% |
| Q2 2021 | $1,184,000 | +35.6% | 18,800 | +100.0% | 0.00% | -33.3% |
| Q1 2021 | $873,000 | +3.7% | 9,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $842,000 | -13.3% | 9,400 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $971,000 | +64.6% | 9,400 | -7.8% | 0.00% | +300.0% |
| Q1 2020 | $590,000 | +40.1% | 10,200 | +59.4% | 0.00% | -50.0% |
| Q3 2018 | $421,000 | -38.7% | 6,400 | -52.9% | 0.00% | -33.3% |
| Q2 2018 | $687,000 | -4.1% | 13,600 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $716,000 | -41.2% | 13,600 | -48.1% | 0.00% | -40.0% |
| Q4 2017 | $1,218,000 | -74.3% | 26,200 | -77.6% | 0.01% | -75.0% |
| Q3 2017 | $4,737,000 | +1841.4% | 117,100 | +1526.4% | 0.02% | +1900.0% |
| Q2 2017 | $244,000 | +16.7% | 7,200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $209,000 | -53.7% | 7,200 | -47.6% | 0.00% | -50.0% |
| Q4 2016 | $451,000 | -83.3% | 13,735 | -84.0% | 0.00% | -83.3% |
| Q3 2016 | $2,705,000 | +65.8% | 85,800 | +47.9% | 0.01% | +71.4% |
| Q2 2016 | $1,631,000 | -47.9% | 58,000 | -32.6% | 0.01% | -50.0% |
| Q1 2016 | $3,129,000 | -20.1% | 86,100 | -12.1% | 0.01% | -17.6% |
| Q4 2015 | $3,917,000 | +40.0% | 97,900 | -0.3% | 0.02% | +54.5% |
| Q3 2015 | $2,798,000 | -6.7% | 98,200 | +7.9% | 0.01% | -8.3% |
| Q2 2015 | $2,998,000 | -43.0% | 91,000 | -50.3% | 0.01% | -45.5% |
| Q1 2015 | $5,263,000 | +15.6% | 183,000 | +9.4% | 0.02% | +22.2% |
| Q4 2014 | $4,554,000 | +327.2% | 167,256 | +234.5% | 0.02% | +260.0% |
| Q3 2014 | $1,066,000 | +6.7% | 50,000 | +12.4% | 0.01% | +25.0% |
| Q2 2014 | $999,000 | -8.9% | 44,500 | +2.5% | 0.00% | -20.0% |
| Q1 2014 | $1,097,000 | -1.8% | 43,400 | -10.7% | 0.01% | 0.0% |
| Q4 2013 | $1,117,000 | +13.9% | 48,600 | -5.6% | 0.01% | 0.0% |
| Q3 2013 | $981,000 | +40.9% | 51,473 | +6.6% | 0.01% | +25.0% |
| Q2 2013 | $696,000 | – | 48,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |